Newly appointed Talkspace advisor Dr. Andrew Sekel is impressed with the progress of text-based health and looks forward to the upcoming findings of efficacy out of Columbia University and Duke University.
Researchers at Columbia University have developed an algorithm that can determine how an individual will react to a drug - paving the way for drugs with fewer side effects, or finding new therapeutic uses for existing medications.
How can text message-based therapy provide better outcomes for patients who are unable to receive face-to-face treatment?
Dr. Oz took to his daytime TV show to defend himself from the recent criticism following a letter sent to Columbia University from 10 doctors.
Dr. Oz has gotten even more heat as of late for his recommendation of "quack treatments" on his daytime TV show. He plans to respond to that criticism in a special episode likely set for Thursday.
Dr. Robert Taub, renowned oncologist and the director of Columbia’s Mesothelioma Center, which handles asbestos-related cancer, is right in the middle of the multimillion-dollar bribery case against state Assembly Speaker Sheldon Silver as a key witness, DNAinfo reports. Apparently a deal was put together that led to Taub referring his patients to Silver’s law firm, Weitz […]
A specialty drug is a class of prescription medications used to treat complex, chronic or rare medical conditions. Although this classification was originally intended to define the treatment of rare, also termed “orphan” diseases, affecting fewer than 200,000 people in the US, more recently, specialty drugs have emerged as the cornerstone of treatment for chronic and complex diseases such as cancer, autoimmune conditions, diabetes, hepatitis C, and HIV/AIDS.
Five companies from molecular diagnostics to smartphone virtual reality simulators to treat anxiety disorders, representing a few countries are vying for World Cup honors in an inaugural competition organized by HITLAB at Columbia University next month. The U.S. seems to have the homefield advantage, with three of the companies hailing from California. The decision to […]
It’s been pretty well documented now that your tastes (sweet, salty, bitter, sour or umami) are divided up on the tongue – is a myth. The reality is that each of the roughly 8,000 taste buds scattered over the tongue is capable of sensing all of the tastes – special cells within those taste buds determine which […]
New York regenerative medicine startup EpiBone‘s tagline is apt: “Grow your own bone.” It uses a patient’s own stem cells to create transplantable, highly personalized bone grafts, going after a 900,000-strong market of patients that need some variety of bone graft to treat, say, severe bone trauma, growth defects or genetic disorders. The company is showcased as one […]
